Navigation Links
C3i and Bristol-Myers Squibb to Discuss the Effects of Oracle Clinical 4.5.3 Zero Footprint on Support Services at the Oracle Health Sciences User Group Conference

SAN ANTONIO, Texas, Oct. 5 /PRNewswire/ -- C3i, the leader in technology services for the life sciences industry, and Bristol-Myers Squibb (BMS), a leading global biopharmaceutical company, will deliver a joint presentation discussing the advantages realized from upgrading to the newest version of Oracle Clinical/Remote Data Capture (OCRDC) software. The presentation will take place in October during the Oracle Health Sciences User Group conference (OHSUG) in San Antonio, TX October 10-13.

The presentation, titled "The Direct and Indirect Effects Upgrading to Zero Footprint has on Clinical Services", investigates several support areas of interest including site assessment, connectivity, laptop provisioning and software issues. Based on quantitative data gathered from BMS operations, Darlene Kalinowski, Associate Director, EDC Operations at BMS and Warren Ryanes, Account Director at C3i will demonstrate the benefits to clinical trial sponsors of upgrading to OCRDC 4.5.3. The "before" and "after" case study will show improvements in material, time and costs. The two presenters will highlight how a "zero footprint" and a decrease in 3rd party plug-ins results in cost savings in areas as diverse as shipping and connectivity, and in fewer support cases related to data entry, navigation, and reports.

"The Oracle Health Sciences User Group conference is a great place to exchange knowledge on Oracle products and related services .We are excited to share the positive experience of BMS with our colleagues from the industry," said Darlene Kalinowski. Warren Ryanes added: "BMS is a great partner. C3i is delighted to have the opportunity work with Darlene and her team to achieve such excellent results."

About C3i: Headquartered in Morristown, New Jersey, C3i Inc. has global operations centers in the United States, India and Bulgaria. Their 1000 employees provide consulting, systems implementation, technology training, multi-lingual help desk, hardware provisioning and break/fix, asset management, hosting, and user/application administration services for pharmaceutical companies worldwide. To learn more, visit and follow us on Twitter at

About Bristol-Myers Squibb Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit or follow us on Twitter at Dave Hanaman C3i 973-401-4677

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon
2. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
3. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
4. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
5. Pressure BioSciences, Inc. to Discuss Second Quarter 2008 Financial Results and Provide Business Update
6. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
7. [video] Jacques Tizabi, CEO of Universal Detection Technology Discusses Latest Purchase Order on WallSt.nets 3-Minute Press Show
8. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
9. VentriPoint Diagnostics Files Management Discussion and Analysis, Unaudited Financial Results for 2Q 2008
10. Anesiva Announces Conference Call and Webcast to Discuss Updates to Corporate Strategy and Milestones
11. Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Partnering Plans for Dimebon
Post Your Comments:
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one of ... their brand, UP4™ Probiotics, into Target stores nationwide. The company, which has been ... Target to its list of well-respected retailers. This list includes such fine stores ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... , June 23, 2016 On Wednesday, ... at 4,833.32, down 0.22%; the Dow Jones Industrial Average edged ... closed at 2,085.45, down 0.17%. has initiated coverage on ... ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals ... (NASDAQ: BIND ). Learn more about these stocks ...
Breaking Biology Technology:
(Date:6/15/2016)... , June 15, 2016 ... report titled "Gesture Recognition Market by Application Market - Global Industry ... - 2024". According to the report, the  global gesture ... in 2015 and is estimated to grow at ... billion by 2024.  Increasing application of ...
(Date:6/9/2016)... 2016 Paris Police Prefecture ... security solution to ensure the safety of people and operations ... the major tournament Teleste, an international technology group ... announced today that its video security solution will be utilised ... up public safety across the country. The system roll-out is ...
(Date:6/3/2016)... Das DOTM (Department ... hat ein 44 Millionen $-Projekt ... einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an Decatur ... Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale Anbieter ... aber Decatur wurde als konformste und innovativste ...
Breaking Biology News(10 mins):